Release Date: 16/08/13 11:13 Summary: Appendix 4E & Annual Report Price Sensitive: Yes Download Document 2.29MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%